| Nov 21 |
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
|
| Nov 18 |
Top US Penny Stocks To Watch In November 2024
|
| Nov 17 |
Dyadic International, Inc. (DYAI) Q3 2024 Earnings Call Transcript
|
| Nov 13 |
DYAI: Milestones Achieved; Product Revenues Next?
|
| Nov 13 |
Dyadic International Inc (DYAI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...
|
| Nov 12 |
Dyadic International GAAP EPS of -$0.01 beats by $0.06, revenue of $1.95M beats by $0.85M
|
| Nov 12 |
Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 4 |
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
|
| Oct 9 |
Dyadic International Inc (DYAI) Q2 2024 Earnings Call Highlights: Strategic Positioning Amid ...
|
